V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003578 | 300002500 | 1.78 | 94.6 | Palliative (P) | 2015-01-28 | 2015-01-28 | CISPLATIN + FLUOROURACIL | N | N | 300016082 | CISPLATIN + FLUOROURACIL |
| 300003579 | 300002501 | 1.7 | 59.1 | Adjuvant (A) | 2015-03-11 | 2015-03-11 | Capecitabine | N | N | 300016085 | CAPECITABINE |
| 300003580 | 300002502 | 1.65 | 56.6 | Curative (C) | 2014-12-29 | 2015-01-05 | Capecitabine | N | N | 300016088 | CAPECITABINE |
| 300003581 | 300002503 | null | null | Curative (C) | 2017-08-17 | 2017-08-30 | CETUXIMAB + RT | 02 | Y | 300016095 | CETUXIMAB + RT |
| 300003582 | 300002504 | 1.45 | 77 | Curative (C) | 2014-11-22 | 2014-11-29 | CETUXIMAB + RT | 02 | null | 300016100 | CETUXIMAB + RT |
| 300003583 | 300002505 | 1.5 | null | Curative (C) | null | 2017-05-22 | Carboplatin + Paclitaxel (3 weekly) | Y | null | 300016105 | CARBOPLATIN + PACLITAXEL |
| 300003584 | 300002505 | 1.72 | 72.5 | null | 2013-08-07 | 2013-09-04 | Cisplatin + Docetaxel +Fluorouracil | Y | null | 300016105 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003585 | 300002505 | 1.77 | 77.7 | 4 | 2015-10-30 | 2015-11-17 | CISPLATIN + FLUOROURACIL | 02 | N | 300016105 | CISPLATIN + FLUOROURACIL |
| 300003586 | 300002506 | 1.6 | 80.2 | Curative (C) | 2017-05-28 | 2017-06-09 | CETUXIMAB | N | Y | 300016118 | CETUXIMAB |
| 300003587 | 300002506 | 1.7 | 75 | Curative (C) | 2014-05-29 | 2014-06-04 | Cetuximab 7 day (Cycle 1) | 02 | null | 300016118 | CETUXIMAB |
| 300003588 | 300002506 | 1.55 | 72.6 | null | 2014-01-26 | 2014-01-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016118 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003589 | 300002506 | 1.64 | null | Neo-adjuvant (N) | 2017-10-27 | 2017-10-27 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 300016118 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003590 | 300002507 | 1.6 | 79.6 | Palliative (P) | 2017-11-30 | 2017-12-24 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 300016139 | CARBOPLATIN + PACLITAXEL |
| 300003591 | 300002508 | 1.44 | null | Curative (C) | 2015-09-04 | 2015-09-13 | CETUXIMAB + RT | Y | Y | 300016142 | CETUXIMAB + RT |
| 300003592 | 300002509 | null | null | Neo-adjuvant (N) | 2015-09-18 | 2015-09-30 | Cisplatin +Fluorouracil (3 wk) | N | N | 300016143 | CISPLATIN + FLUOROURACIL |
| 300003593 | 300002510 | 1.8 | 46 | Neo-adjuvant (N) | 2016-11-11 | 2016-11-20 | CISPLATIN + FLUOROURACIL | N | N | 300016145 | CISPLATIN + FLUOROURACIL |
| 300003594 | 300002511 | 1.66 | null | Neo-adjuvant (N) | 2014-04-11 | 2014-04-11 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 300016147 | CARBOPLATIN + PACLITAXEL |
| 300003595 | 300002512 | 1.63 | 57.7 | null | 2013-09-18 | 2013-09-25 | Cetuximab + Radiotherapy Load | 02 | Y | 300016148 | CETUXIMAB + RT |
| 300003596 | 300002513 | 1.7 | 67.7 | Neo-adjuvant (N) | 2015-02-17 | 2015-03-15 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 300016154 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003597 | 300002514 | 1.76 | null | Adjuvant (A) | 2013-03-29 | 2013-04-12 | Capecitabine | 02 | N | 300016156 | CAPECITABINE |
| 300003602 | 300002516 | 1.67 | null | Neo-adjuvant (N) | 2016-06-26 | 2016-06-26 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016173 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003603 | 300002517 | 1.55 | 97 | Curative (C) | 2015-10-27 | 2015-11-02 | CETUXIMAB + RT | 02 | Y | 300016175 | CETUXIMAB + RT |
| 300003604 | 300002518 | 1.54 | 102.8 | Palliative (P) | 2015-01-29 | 2015-03-07 | Trial Unspecified | N | N | 300016176 | TRIAL |
| 300003605 | 300002519 | 1.72 | 87.1 | Adjuvant (A) | 2016-05-06 | 2017-04-05 | Capecitabine | N | N | 300016179 | CAPECITABINE |
| 300003606 | 300002520 | null | null | Curative (C) | 2017-10-25 | 2017-11-23 | CETUXIMAB + RT | N | Y | 300016180 | CETUXIMAB + RT |
| 300003607 | 300005964 | 1.89 | 86 | Curative (C) | 2016-03-24 | 2016-04-03 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300016182 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003608 | 300002521 | 1.63 | 83 | Neo-adjuvant (N) | 2017-02-26 | 2017-03-04 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 300016184 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003609 | 300002522 | 1.52 | 65 | Neo-adjuvant (N) | 2016-07-24 | 2016-08-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300016190 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003610 | 300002523 | 1.56 | null | null | 2017-03-06 | 2017-03-29 | Cetuximab 7 day (>Cycle 2) | Y | Y | 300016194 | CETUXIMAB |
| 300003611 | 300002524 | 1.85 | 69.4 | Adjuvant (A) | 2016-11-27 | 2016-12-04 | Trial Unspecified | N | N | 300016204 | TRIAL |
| 300003612 | 300002525 | 1.72 | null | Disease modification (D) | 2017-10-25 | 2017-10-27 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300016207 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003613 | 300002525 | 1.86 | 60 | null | 2017-12-25 | 2017-12-30 | BILCAP TRIAL | N | null | 300016207 | TRIAL |
| 300003614 | 300002526 | 1.58 | 81.7 | Palliative (P) | 2013-10-10 | 2013-11-06 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300016210 | CARBOPLATIN + PACLITAXEL |
| 300003616 | 300002528 | 1.74 | 85 | Curative (C) | 2019-01-16 | 2019-02-02 | Cetuximab 7 day (Cycle 1) | 02 | Y | 300016213 | CETUXIMAB |
| 300003617 | 300002529 | 1.6 | 70 | null | 2013-02-10 | 2013-02-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016214 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003618 | 300002530 | 1.62 | 76 | Neo-adjuvant (N) | 2013-12-07 | 2013-12-12 | CISPLATIN + FLUOROURACIL | 02 | null | 300016215 | CISPLATIN + FLUOROURACIL |
| 300003619 | 300005966 | 1.75 | 111.6 | Adjuvant (A) | 2013-12-07 | 2013-12-13 | Capecitabine | 02 | N | 300016220 | CAPECITABINE |
| 300003620 | 300002531 | 1.52 | 71 | Neo-adjuvant (N) | 2017-10-15 | 2017-10-17 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300016222 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003621 | 300002531 | null | 76.9 | Neo-adjuvant (N) | 2017-09-30 | 2017-10-01 | Cisplatin +Fluorouracil (3 wk) | null | null | 300016222 | CISPLATIN + FLUOROURACIL |
| 300003622 | 300002532 | 1.77 | 115.35 | Curative (C) | 2014-11-06 | 2014-12-04 | Trial Unspecified | 02 | N | 300016225 | TRIAL |
| 300003623 | 300002533 | 1.8 | 77 | Adjuvant (A) | 2017-12-16 | 2017-12-23 | Capecitabine | N | N | 300016227 | CAPECITABINE |
| 300003624 | 300002533 | 1.57 | 80.6 | Adjuvant (A) | 2017-07-27 | 2017-08-08 | Capecitabine | N | N | 300016227 | CAPECITABINE |
| 300003625 | 300002533 | 1.81 | 45 | Curative (C) | 2017-10-08 | 2017-10-28 | CISPLATIN + FLUOROURACIL | 02 | N | 300016227 | CISPLATIN + FLUOROURACIL |
| 300003626 | 300002534 | null | 89 | Curative (C) | 2015-02-07 | 2015-02-22 | Cetuximab + Radiotherapy Load | N | Y | 300016240 | CETUXIMAB + RT |
| 300003627 | 300002535 | 1.52 | 63 | Palliative (P) | 2016-02-02 | 2016-02-10 | Trial Unspecified | 02 | null | 300016249 | TRIAL |
| 300003629 | 300002537 | null | 78.3 | Curative (C) | null | 2014-12-12 | Cetuximab 7 day (Cycle 1) | N | Y | 300016263 | CETUXIMAB |
| 300003630 | 300002538 | null | null | Curative (C) | 2013-11-29 | 2013-12-07 | Cetuximab + Radiotherapy Load | 02 | Y | 300016265 | CETUXIMAB + RT |
| 300003632 | 300002540 | 1.6 | 97.7 | Curative (C) | 2013-03-09 | 2013-04-08 | Cetuximab + Radiotherapy Maint | 02 | Y | 300016273 | CETUXIMAB + RT |
| 300003633 | 300002541 | 1.8 | 98 | Curative (C) | 2013-03-01 | 2013-03-11 | CISPLATIN + FLUOROURACIL | 02 | null | 300016274 | CISPLATIN + FLUOROURACIL |
| 300003634 | 300002542 | 1.68 | 43.15 | Neo-adjuvant (N) | 2016-10-17 | 2016-10-20 | CISPLATIN + FLUOROURACIL | 02 | N | 300016276 | CISPLATIN + FLUOROURACIL |